-+ 0.00%
-+ 0.00%
-+ 0.00%

Ascletis Pharma files HKEX next-day disclosure return on share repurchase for cancellation

PUBT·07/14/2026 09:33:22
Listen to the news
Ascletis Pharma files HKEX next-day disclosure return on share repurchase for cancellation
  • Ascletis filed a next-day disclosure return to HKEX covering a 200,000-share buyback for cancellation on July 14, 2026.
  • Repurchase price range HKD 10.19 to HKD 11.31; total consideration HKD 2.09 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascletis Pharma Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260714-12243699), on July 14, 2026, and is solely responsible for the information contained therein.